173 related articles for article (PubMed ID: 30110981)
21. Induction of Cytotoxicity in Pyridine Analogues of the Anti-metastatic Ru(III) Complex NAMI-A by Ferrocene Functionalization.
Mu C; Chang SW; Prosser KE; Leung AW; Santacruz S; Jang T; Thompson JR; Yapp DT; Warren JJ; Bally MB; Beischlag TV; Walsby CJ
Inorg Chem; 2016 Jan; 55(1):177-90. PubMed ID: 26652771
[TBL] [Abstract][Full Text] [Related]
22. Probing ruthenium-acetylide bonding interactions: synthesis, electrochemistry, and spectroscopic studies of acetylide-ruthenium complexes supported by tetradentate macrocyclic amine and diphosphine ligands.
Wong CY; Che CM; Chan MC; Han J; Leung KH; Phillips DL; Wong KY; Zhu N
J Am Chem Soc; 2005 Oct; 127(40):13997-4007. PubMed ID: 16201822
[TBL] [Abstract][Full Text] [Related]
23. Mixed-valent metals bridged by a radical ligand: fact or fiction based on structure-oxidation state correlations.
Sarkar B; Patra S; Fiedler J; Sunoj RB; Janardanan D; Lahiri GK; Kaim W
J Am Chem Soc; 2008 Mar; 130(11):3532-42. PubMed ID: 18290644
[TBL] [Abstract][Full Text] [Related]
24. 1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for the preparation of ruthenium complexes with potential anticancer activity.
Bratsos I; Urankar D; Zangrando E; Genova-Kalou P; Košmrlj J; Alessio E; Turel I
Dalton Trans; 2011 May; 40(19):5188-99. PubMed ID: 21465046
[TBL] [Abstract][Full Text] [Related]
25. Multifunctional DNA interactions of Ru-Pt mixed metal supramolecular complexes with substituted terpyridine ligands.
Jain A; Wang J; Mashack ER; Winkel BS; Brewer KJ
Inorg Chem; 2009 Oct; 48(19):9077-84. PubMed ID: 19739630
[TBL] [Abstract][Full Text] [Related]
26. Visible-Light-Driven Photoisomerization and Increased Rotation Speed of a Molecular Motor Acting as a Ligand in a Ruthenium(II) Complex.
Wezenberg SJ; Chen KY; Feringa BL
Angew Chem Int Ed Engl; 2015 Sep; 54(39):11457-61. PubMed ID: 26271465
[TBL] [Abstract][Full Text] [Related]
27. Binuclear ruthenium(III) bis(thiosemicarbazone) complexes: synthesis, spectral, electrochemical studies and catalytic oxidation of alcohol.
Mohamed Subarkhan M; Ramesh R
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Mar; 138():264-70. PubMed ID: 25498823
[TBL] [Abstract][Full Text] [Related]
28. Tuning the cytotoxic properties of new ruthenium(III) and ruthenium(II) complexes with a modified bis(arylimino)pyridine Schiff base ligand using bidentate pyridine-based ligands.
Garza-Ortiz A; Maheswari PU; Lutz M; Siegler MA; Reedijk J
J Biol Inorg Chem; 2014 Jun; 19(4-5):675-89. PubMed ID: 24430199
[TBL] [Abstract][Full Text] [Related]
29. Exploring the noninnocent character of electron rich π-extended 8-oxyquinolate ligands in ruthenium(II) bipyridyl complexes.
Bellinger-Buckley S; Chang TC; Bag S; Schweinfurth D; Zhou W; Torok B; Sarkar B; Tsai MK; Rochford J
Inorg Chem; 2014 Jun; 53(11):5556-67. PubMed ID: 24840779
[TBL] [Abstract][Full Text] [Related]
30. Octahedral Fe(II) and Ru(II) complexes based on a new bis 1,10-phenanthroline ligand that imposes a well defined axis.
Pomeranc D; Heitz V; Chambron JC; Sauvage JP
J Am Chem Soc; 2001 Dec; 123(49):12215-21. PubMed ID: 11734021
[TBL] [Abstract][Full Text] [Related]
31. Iron(II) tris-[N4-substituted-3,5-di(2-pyridyl)-1,2,4-triazole] complexes: structural, magnetic, NMR, and density functional theory studies.
Kitchen JA; White NG; Boyd M; Moubaraki B; Murray KS; Boyd PD; Brooker S
Inorg Chem; 2009 Jul; 48(14):6670-9. PubMed ID: 19534510
[TBL] [Abstract][Full Text] [Related]
32. 4,5-di(2-pyridyl)-1,2,3-triazolate: the elusive member of a family of bridging ligands that facilitate strong metal-metal interactions.
Richardson C; Fitchett CM; Keene FR; Steel PJ
Dalton Trans; 2008 May; (19):2534-7. PubMed ID: 18443694
[TBL] [Abstract][Full Text] [Related]
33. Substitution reactions in dinuclear Ru-Hbpp complexes: an evaluation of through-space interactions.
Planas N; Christian G; Roeser S; Mas-Marzá E; Kollipara MR; Benet-Buchholz J; Maseras F; Llobet A
Inorg Chem; 2012 Feb; 51(3):1889-901. PubMed ID: 22242940
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and characterisation of ruthenium complexes containing a pendent catechol ring.
O'Brien L; Duati M; Rau S; Guckian AL; Keyes TE; O'Boyle NM; Serr A; Görls H; Vos JG
Dalton Trans; 2004 Feb; (4):514-22. PubMed ID: 15252512
[TBL] [Abstract][Full Text] [Related]
35. Distinctive Aspects in Aquation, Proton-Coupled Redox, and Photoisomerization Reactions between Geometric Isomers of Mononuclear Ruthenium Complexes with a Large-π-Conjugated Tetradentate Ligand.
Tsubonouchi Y; Watanabe T; Yoshida K; Watabe S; Inaba K; Hirahara M; Hatanaka T; Funahashi Y; Chandra D; Hoshino N; Zahran ZN; Yagi M
Inorg Chem; 2022 Sep; 61(35):13956-13967. PubMed ID: 36000984
[TBL] [Abstract][Full Text] [Related]
36. Emission switching of ferrocenyl Schiff bases and a representative ruthenium complex in alkaline DMSO: absorption, electrochemical and microstructural studies.
Mishra L; Dubey SK
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Oct; 68(2):364-8. PubMed ID: 17324612
[TBL] [Abstract][Full Text] [Related]
37. Mixed-ligand Ru(II) complexes with 2,2'-bipyridine and tetradentate Schiff bases auxiliary ligands: Synthesis, physico-chemical study, DFT analysis, electrochemical and Na+ binding properties.
Mishra L; Prajapati R; Pandey KK
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jun; 70(1):79-85. PubMed ID: 17719837
[TBL] [Abstract][Full Text] [Related]
38. Photochemistry of Ru(II) Triazole Complexes with 6-Membered Chelate Ligands: Detection and Reactivity of Ligand-Loss Intermediates.
Eastham K; Kennedy ADW; Scottwell SØ; Bramham JE; Hardman S; Golovanov AP; Scattergood PA; Crowley JD; Elliott PIP
Inorg Chem; 2024 May; 63(20):9084-9097. PubMed ID: 38701516
[TBL] [Abstract][Full Text] [Related]
39. Kinetically labile ruthenium(II) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity.
Kumar P; Singh P; Saren S; Pakira S; Sivakumar S; Patra AK
Dalton Trans; 2021 Jun; 50(23):8196-8217. PubMed ID: 34031678
[TBL] [Abstract][Full Text] [Related]
40. Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release.
Hufziger KT; Thowfeik FS; Charboneau DJ; Nieto I; Dougherty WG; Kassel WS; Dudley TJ; Merino EJ; Papish ET; Paul JJ
J Inorg Biochem; 2014 Jan; 130():103-11. PubMed ID: 24184694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
